APA (7th ed.) Citation

Hoffrogge, R., Karachunskaya, A., Heitmann, N., Haupeltshofer, S., Pedreiturria, X., Klöster, K., . . . Faissner, S. (2025). The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Hoffrogge, Robert, et al. The P2X7R-antagonist AFC-5128 Ameliorates Chronic Experimental Autoimmune Encephalomyelitis in a Preventive and Therapeutic Paradigm. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Hoffrogge, Robert, et al. The P2X7R-antagonist AFC-5128 Ameliorates Chronic Experimental Autoimmune Encephalomyelitis in a Preventive and Therapeutic Paradigm. Frontiers Media S.A, 2025.